2011 State of the Industry Report: Newfoundland and LabradorA status report on the issues affecting pharmacy right now. 2011 State of the Industry Report: Nova ScotiaA status report on the issues affecting pharmacy right now. 2011 State of the Industry Report: Ontario A status report on the issues affecting pharmacy right now. 2011 State of the Industry Report: Quebec A status report on the issues affecting pharmacy right now. 2011 State of the Industry Report: Saskatchewan A status report on the issues affecting pharmacy right now. 2011 State of the Industry Report: The national view A status report on the issues affecting pharmacy right now. Drug News: July/August 2011 Abstral: SL opioid for breakthrough cancer pain and other new products. Adverse reactions: Top 10 suspect drugs Drugs most frequently cited in FDA reports. Adverse Reactions: Antidepressants and cardiovascular disease Prospective cohort study completed to determine if an association between antidepressant use and future risk of CVD exists. Environmental Issues: Food allergies in the school environment Approximately 20% of reactions happen at school, where children may suffer their first severe FA episode. Research Highlights: Methods to improve “real world” efficacy of OCs Two recently published studies investigated two different approaches. Practice Issues: References References for Adverse Reactions, Environmental Issues and Research Highlights. First Previous 1728 1729 1730 1731 1732 Next Last
